Professor Simon Lovestone, from the Institute of Psychiatry, told the annual Alzheimer’s Research Trust conference in central London yesterday that the next five or 10 years could see a breakthrough in the development of treatments for Alzheimer’s.
‘There are 10 or 11 drugs that are in late stage clinical trials, as well as 70-80 more drugs in early stage development.
‘There is a good chance that one of these drugs will work.’
But Professor John Hardy, from the Institute of Neurology at University College London, warned that a lack of commitment and funding for dementia research along with high levels of bureaucracy could slow down the development of new Alzheimer’s drugs.
- Does the government spend enough on research into Alzheimers?
Comment below and tell us what you think